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Abstract: The aim of this study was to assess serum asymmetric dimethyl arginine (ADMA), cardiac troponin I (cTnI), thyroxine (T4),
cholesterol and triglyceride (TG) levels in dogs with normal body condition and obese dogs. A total of 40 dogs (n = 40) were included
in the study and dogs were divided into two groups; 20 dogs with normal body condition and 20 obese dogs. The dogs were grouped
according to the five-point body-condition scoring (BCS) system. Serum ADMA, cTnI, T4, cholesterol, and TG levels were measured
in addition to routine biochemical parameters. Serum ADMA, cTnI, TG, and cholesterol levels were statistically significant between
the two groups (P < 0.001, P < 0.001, P = 0.027, P = 0.006, respectively). There was a positive correlation between the serum cholesterol
levels and both TG and cTnI levels among obese dogs. It is thought that the findings of this study may help future studies in determining
novel biomarkers for obesity in dogs.
Key words: Obesity, dog, asymmetric dimethylarginine, cardiac troponin I, cholesterol, triglyceride

1. Introduction
Obesity is one of the most common malnutrition disorder
among pet animals and humans in recent years [1,2]. In
veterinary medicine, obesity is defined as 15%–20% over
the ideal body weight [3,4]. Obesity is the imbalance
between basal energy intake and consumption [5]. Body
condition scoring (BCS) system is the most common
method for determining the degree of obesity in dogs
[6]. According to the five-point body condition system,
obese dogs have a body condition score of 5, while dogs
with normal body condition have a body condition score
of 3. Obese dogs suffer from respiratory, cardiovascular,
and gastrointestinal system diseases, endocrine and
reproductive disorders, heat intolerance, coagulopathy,
tumors, dyslipidemia, and dermatological diseases [7,8].
Asymmetric dimethyl arginine (ADMA) is an
endogenous inhibitor of nitric oxide synthase, which
is a primary stimulating molecule in cellular functions
[9]. Nitric oxide bioavailability is effective in various
physiological mechanisms, such as vasodilatation, platelet
aggregation, low-density lipid oxidation, smooth muscle
cell proliferation, superoxide radical regulator, and
monocyte adhesion [10,11].
Cardiovascular diseases are one of the major
complications of obesity [12]. Cardiac troponin I (cTnI)

is a specific and sensitive biomarker in cardiac disease
in dogs, cats, laboratory animals and humans [13-16].
Moreover, cTnI was evaluated as a marker in dogs with
gastric dilatation volvulus, babesiosis, and cardiac damage
[14,17,18].
Thyroxine (T4) hormone is secreted from thyroid
gland and is either bound to proteins or in the free state
[19]. Thyroid hormones are strong regulators of basal
metabolism, and also have various functions in the
metabolism [20,21].
Dyslipidemia, which is commonly observed in dogs,
is characterized by an increase in serum triglyceride
(TG) or serum cholesterol levels or even both [22,23].
Triglycerides consist of fatty acids and glycerol which are
synthesized in the liver. They are an important source
of energy. When the blood glucose level falls, they are
broken down to fatty acids, and fatty acids are released
into the circulatory system for energy metabolism [19].
Cholesterol is an important material for cell membranes
[24]. The required amount of cholesterol is synthesized
in the body; however, the excess amount of cholesterol is
accumulated in the veins when it is taken extensively by
nutrition. Obesity-induced lipid metabolism disorders
play a significant role in the formation of obesity-related
diseases [25]. According to Cardoso et al. [26], an increase
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in body condition score results in an increase in systolic
hypertension and total cholesterol.
The aim of this study was to assess the levels of
biochemical parameters, such as ADMA, cTnI, T4, TG,
and cholesterol, in dogs with normal body condition and
in obese dogs.
2. Materials and methods
This study was performed between February 2017 and
December 2017 at Bursa Uludağ University, Veterinary
Faculty, Internal Medicine Clinics of Animal Teaching
Hospital. The study groups consisted of 20 dogs with normal
body condition and 20 obese dogs (n = 40). Dogs with no
clinical signs of any disease and not receiving any treatment
were included in the study after completing the routine
clinical examination and obtaining the consent of their
owner. According to the five-point body condition scale
of the American Animal Hospital Association (AAHA),
dogs with a body condition score of 5 were defined as obese
and those with a body condition score of 3 were defined as
normal.
Blood samples were collected from the cephalic vein
into a silicone-coated sterile serum tube containing 10
mL of clotting activator (Hema & Lab Products Medical
Co. Ltd., Turkey). The serum samples were separated by
centrifugation (1200 rpm, 10 min) and stored at −80 ℃
until analysis.
MyBio Source test kit was used to analyze ADMA
(MyBio Source Inc., USA) and SunLong Biotech test kit was
used to analyze cTnI by ELISA method (SunLong Biotech
Co. Ltd. China) via Biotek ELx808 Absorbance Microplate
Reader (BioTek Instruments Inc., Winooski, VT, USA).
The levels of cholesterol and T4 were measured using
VetScan Thyroxine (T4)/Cholesterol (Chol) Panel (Abaxis
Inc., Union City, CA, USA). TG and routine biochemical
parameters were measured using VetScan Comprehensive
Profile (Abaxis Inc).
Statistical analyses were performed via SigmaPlot 14
(Systat Software Inc. CA, USA). Mann–Whitney U and
t-test were used to determine the difference between the
groups. Spearman’s correlation test was performed to
analyze correlation. The P-value <0.05 was accepted as
statistically significant.
This study was approved by the Ethical Committee of
Bursa Uludağ University Animal Experiments (No. 201608/01).
3. Results
Serum ADMA, cTnI, T4, TG, and cholesterol levels were
compared among the groups. The levels of serum ADMA,
cTnI, TG, and cholesterol levels were found to be lower in
the dogs with a body condition score of 3 than the dogs with
a body condition score of 5 (P < 0.001, P < 0.001, P = 0.027,
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P = 0.006, respectively) (Table 1). Serum T4 levels did not
differ significantly between the two groups (P = 0.642).
The correlations between serum ADMA, cTnI, T4,
cholesterol, and TG levels in the obese dogs are shown in
Table 2. Correlations were performed using the Spearman
test. A positive correlation was determined between serum
cTnI and cholesterol levels, and between serum TG and
cholesterol levels in obese dogs (P = 0.0476, P = 0.00281,
respectively).
No statistical difference was found in the correlation
analysis performed between serum ADMA, cTnI, T4, and
cholesterol levels of the dogs with body condition score 3.
There was a negative correlation between serum ADMA
and TG levels (P = 0.0195).
4. Discussion
Several studies have revealed that the levels of certain
biochemical parameters varied in obesity and related
diseases [12,20,27–31]. It is stated that there is a positive
relationship between obesity and ADMA in studies
conducted with obese people [12,28]. In this study, there
was a significant difference between the ADMA levels of
obese dogs and dogs with normal body condition (P <
0.05). However, no study has been performed regarding the
relationship between obesity and ADMA in dogs.
In a study conducted in mice, obesity was experimentally
induced with a high-fat diet and increased ADMA levels
were observed [32]. In this study, the levels of dimethyl
arginine dimethyl amino hydrolase (DDAH) enzyme,
which is involved in ADMA metabolism and expressed in
liver, showed a decrease due to fatty liver. Hence, fatty liver
resulted in an increase in the ADMA level [32].
Adipocytokines secreted physiologically by adipocyte
tissue provide hemostasis of lipid metabolism. The disorders
of lipid metabolism are occurred in obesity that is induced
by disorders in adipose tissue metabolism [33]. In the study,
serum TG and cholesterol levels, which were found to be
high in obese dogs when compared to those with normal
body condition, supported the obesity-related changes
in lipid metabolism. Meanwhile, the serum cholesterol
and TG levels in the obese group also showed a positive
correlation with dyslipidemia in obesity.
Hypercholesterolemia, which results in impaired lipid
metabolism, increases the risk of cardiovascular disease
because it causes both atherosclerosis and decreased
aggregation and distortion of erythrocyte membrane
flexibility in the circulation [34–37]. The negative effect of
obesity on lipid metabolism increases cholesterol levels,
which can lead to cardiovascular disorders [25,38–40].
cTnI is a frequently used biomarker in the identification
of cardiovascular diseases in dogs [16]. In the study,
serum cholesterol level, which was higher in the obese
dogs than those with normal body condition, showed
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Table 1. According to BCS (3 and 5) mean ± SEM, maximum - minimum value of blood serum parameters
(ADMA, cTnI, T4, TG, cholesterol, TP, and GLOB) in dogs.
BCS = 3 Mean ± SEM/
Min - Max (n = 20)

BCS = 5 Mean ± SEM/
Min - Max (n = 20)

0.759 ± 0.109
0.051 - 2.412

1.179 ± 0.107
0.899 - 2.451

304.700 ± 5.628
274.000 - 398.000

481.800 ± 7.600
389.000 - 516.000

P < 0.001

T4 (µg/dL)

1.615 ± 0.145
0.500 - 2.600

1.730 ± 0.198
0 - 3.600

P = 0.642

TG (mg/dL)

99.400 ± 5.367
70.000 - 153.000

145.390 ± 2 0.011
70.000 - 465.000

P = 0.027

Cholesterol (mg/dl)

176.750 ± 8.314
101.000 - 253.000

248.450 ± 21.058
139.000 - 520.000

P = 0.006

TP (g/dL)

7.010 ± 0.183
5.900 - 8.800

7.065 ± 0.212
6.100 - 9.800

P = 0.978

GLOB (g/dL)

3.445 ± 0.205
2.200 - 5.200

3.270 ± 0.245
2.400 - 6.700

P = 0.336

Parameter
ADMA (µmol/L)
cTnI (pg/mL)

P-value
P < 0.001

Table 2. Correlations between serum ADMA, cTnI, T4, cholesterol and TG in 20 obese dogs.

Parameter

cTnI (pg/mL)
Correlation coefficient
P-value

ADMA (µmol/L)
Correlation coefficient
P-value

T4 (µg/dL)
Correlation coefficient
P-value

Cholesterol (mg/dL)
Correlation coefficient
P-value

TG (mg/dL)

0.439
0.0519

0.154
0.513

−0.144
0.538

0.632
0.00281

Cholesterol (mg/dL)

0.446
0.0476

0.191
0.414

0.234
0.314

T4 (µg/dL)

−0.0889
0.705

0.177
0.448

ADMA (µmol/L)

−0.0459
0.841

a positive correlation with the cTnI level. This finding
supports the association between the cholesterol levels and
cardiovascular markers which are increased as a result of
the negative effects of obesity on lipid metabolism.
In the present study, serum total T4 levels did not differ
between dogs with normal body condition and obese dogs.
In a study conducted in obese pigs, T4 levels were reported
to be at normal levels [41]. In the circulatory system, 75%
of T4 hormone is bound to alpha globulin physiologically
[19]. According to the findings of this study, there was
no difference in serum total protein (TP) and globulin
(GLOB) levels between the two groups. Therefore, the lack
of difference in serum T4 levels between the groups can be
related to the lack of difference in serum total protein and
globulin levels.
In conclusion, the results obtained from this study
should be taken into consideration for the evaluation

of obese dogs and the related risk factors. In this study,
findings revealed that serum the ADMA levels in obese
dogs were higher than dogs with normal body condition.
Moreover, the serum cTnI, cholesterol, and TG levels
were also higher in obese dogs than those with normal
body condition. However, there was a positive correlation
between the serum TG and cholesterol levels, and between
the cTnI and cholesterol levels in the group consisted of
obese dogs. The serum T4 levels did not show variation
between the two study groups.
This study will contribute to the future studies that
will be performed to reveal novel biomarkers of obesity in
dogs.
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